Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study (2014)
- Authors:
- Autor USP: MUSSI, MARISA MARCIA - FMRP
- Unidade: FMRP
- DOI: 10.1111/hiv.12141
- Subjects: PEDIATRIA; FARMACOCINÉTICA; ANTIVIRAIS; INFECÇÕES POR HIV
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2014
- Source:
- Título: HIV Medicine
- ISSN: 1464-2662
- Volume/Número/Paginação/Ano: v. 15, n. 9, p. 513-524, 2014
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
TUDOR-WILLIAMS, G. et al. Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study. HIV Medicine, v. 15, n. 9, p. 513-524, 2014Tradução . . Disponível em: https://doi.org/10.1111/hiv.12141. Acesso em: 11 jan. 2026. -
APA
Tudor-Williams, G., Cahn, P., Chokephaibulkit, K., Fourie, J., Karatzios, C., Dincq, S., et al. (2014). Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study. HIV Medicine, 15( 9), 513-524. doi:10.1111/hiv.12141 -
NLM
Tudor-Williams G, Cahn P, Chokephaibulkit K, Fourie J, Karatzios C, Dincq S, Opsomer M, Nakuda TN, Nijs S, Tambuyzer L, Tomaka FL, Mussi-Pinhata MM. Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study [Internet]. HIV Medicine. 2014 ; 15( 9): 513-524.[citado 2026 jan. 11 ] Available from: https://doi.org/10.1111/hiv.12141 -
Vancouver
Tudor-Williams G, Cahn P, Chokephaibulkit K, Fourie J, Karatzios C, Dincq S, Opsomer M, Nakuda TN, Nijs S, Tambuyzer L, Tomaka FL, Mussi-Pinhata MM. Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study [Internet]. HIV Medicine. 2014 ; 15( 9): 513-524.[citado 2026 jan. 11 ] Available from: https://doi.org/10.1111/hiv.12141 - Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected pregnant women and adverse infant outcomes
- Syphilis in HIV-infected mothers and infants
- First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial
- Particularidades imunológicas do pré-termo extremo: um desafio para a prevenção da sepse hospitalar
- Lower respiratory tract infections and hospitalizations among HIV-exposed, uninfected infants born in Latin America
- Detecção qualitativa e quantitativa de partículas virais e anticorpos contra o vírus da Hepatite B (VHB) no sangue e leite de nutrizes AGHBS/Anti-HBc e anti-HBs/anti-HBc positivas
- Prevalência dos marcadores da infecção pelo vírus da hepatite B (VHB) em parturientes: destaque para detecção isolada do marcador anti-HBc
- Three postpartum antiretroviral regimens to prevent intrapartum HIV infection
- Birth prevalaence and characteristics of congenital toxoplasmosis in Sergipe, North-east Brazil
- Missed opportunities for prevention of mother-to-child transmission of HIV-1 in the NISDI perinatal and LILAC cohorts
Informações sobre o DOI: 10.1111/hiv.12141 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
